Edwards Hits Record as Aortic Valves Save More Lives in Study

  • Sapien 3 helps reduce death and stroke in heart patients
  • Results `truly phenomenal,' exceed expectations: Analyst

Edwards Lifesciences Corp. surged to a record after researchers showed its latest heart valve lowered the risk of death and stroke in a broader group of people suffering from severe aortic stenosis, a finding that could swell the market for the products to $5 billion.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.